Andere Sprachen Ningbo Menovo Pharmaceutical Co., Ltd.

Aktien

603538

CNE100002Y25

603538

Schlusskurs Shanghai S.E. Andere Börsenplätze 00:00:00 30.04.2024			% 5 Tage	% 1. Jan.
13.8 ^CNY	+3.84%		+11.47%	-27.82%

29.04.	Ningbo Menovo Pharmaceutical Co., Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
29.04.	Ningbo Menovo Pharmaceutical Co., Ltd. meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Ningbo Menovo Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	29.04.
Ningbo Menovo Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29.04.
Menovo Pharmaceutical Unit Gets Approval to Register Vildagliptin Tablets	23.04.
Ningbo Menovo Pharmaceutical Co., Ltd. cancelled the transaction announced on July 20, 2023	16.04.
Menovo Pharma's Unit Gets Nod to Market Clopidogrel Hydrogen Sulfate Tablets	06.03.
Menovo Pharma Gets Nod to Market Raw Drug Ingredient for Hypertension Into EU Market; Shares Up 3%	04.03.
Ningbo Menovo Pharmaceutical Co., Ltd.(XSSC:603538) dropped from S&P Global BMI Index	18.12.
Ningbo Menovo Pharma Registers Seizure Drug in China	05.12.
Ningbo Menovo Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27.10.23
Menovo Pharmaceutical Unit's Rosuvastatin Calcium Passes Drug Regulator's Technical Review	11.10.23
Ningbo Menovo Pharmaceutical Co., Ltd.(XSSC:603538) added to S&P Global BMI Index	18.09.23
Ningbo Menovo Pharma Registers Blood Pressure Drug	06.09.23
Ningbo Menovo Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	30.08.23
Ningbo Menovo Pharmaceutical Co., Ltd. announced that it expects to receive CNY 652 million in funding from Ningbo Menovo Holding Group Co., Ltd. and other investors	20.07.23
Ningbo Menovo Pharmaceutical Co., Ltd. announced that it expects to receive CNY 651.999948 million in funding from Ningbo Menovo Holding Group Co., Ltd. and other investors.	20.07.23
Ningbo Menovo Pharmaceutical Co., Ltd. announced that it expects to receive funding from Ningbo Menovo Holding Group Co., Ltd.	20.07.23
Ningbo Menovo Pharmaceutical Co., Ltd. cancelled the transaction announced on August 15, 2022	20.07.23
Menovo Pharmaceutical's Unit Gets Nod to Own Olmesartan Medoxomil Tablets	14.07.23
Menovo Pharma Gets European Certification for Diet Drug	08.06.23
Menovo Pharma Gets Registration Certificate for Moxifloxacin Hydrochloride Tablets	25.05.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Ningbo Menovo Pharmaceutical Co., Ltd.

Aktien

603538

CNE100002Y25

603538

Andere Sprachen

Filter